304
Views
9
CrossRef citations to date
0
Altmetric
Brief Reports

Provider Experiences With the Identification, Management, and Treatment of Co-occurring Chronic Noncancer Pain and Substance Use in the Safety Net

, , , , , & show all

References

  • Baldacchino, A., Gilchrist, G., Fleming, R., & Bannister, J. (2010). Guilty until proven innocent: A qualitative study of the management of chronic non-cancer pain among patients with a history of substance abuse. Addictive Behaviors, 35(3), 270–272.
  • Buck, J. A. (2011). The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Affairs, 30(8), 1402–1410.
  • Busch, S. H., Meara, E., Huskamp, H. A., & Barry, C. L. (2013). Characteristics of adults with substance use disorders expected to be eligible for Medicaid under the ACA. Psychiatric Services, 64(6), 520–526.
  • Charmaz, K. (2014). Constructing grounded theory. London, UK: Sage.
  • Cheung, C. W., Qiu, Q., Choi, S. W., Moore, B., Goucke, R., & Irwin, M. (2014). Chronic opioid therapy for chronic non-cancer pain: a review and comparison of treatment guidelines. Pain Physician, 17(5), 401–414.
  • Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., & Miaskowski, C. (2009). Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. The Journal of Pain, 10(2), 113–130.
  • Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recommendations and Reports, 65, 1–49.
  • Edlund, M. J., Martin, B. C., Devries, A., Fan, M. Y., Braden, J. B., & Sullivan, M. D. (2010). Trends in use of opioids for chronic non-cancer pain among individuals with mental health and substance use disorders: The TROUP study. The Clinical Journal of Pain, 26(1), 1.
  • Hsieh, H. F., & Shannon, S. E. (2005). Three approaches to qualitative content analysis. Qualitative Health Research, 15(9), 1277–1288.
  • Katz, M. H. (2016). Opioid prescribing for chronic pain: Not for the faint of heart. JAMA Internal Medicine, 176(5), 599–601.
  • Krebs, E. E., Bergman, A. A., Coffing, J. M., Campbell, S. R., Frankel, R. M., & Matthias, M. S. (2014). Barriers to guideline-concordant opioid management in primary care—A qualitative study. The Journal of Pain, 15(11), 1148–1155.
  • Lewin, M. E., & Altman, S. (Eds.). (2000). America's health care safety net: Intact but endangered. Retrieved from https://www.nap.edu/catalog/9612.html
  • Lewis, V. A., Colla, C. H., Tierney, K., Van Citters, A. D., Fisher, E. S., & Meara, E. (2014). Few ACOs pursue innovative models that integrate care for mental illness and substance abuse with primary care. Health Affairs, 33(10), 1808–1816.
  • Matthias, M. S., Krebs, E. E., Bergman, A. A., Coffing, J. M., & Bair, M. J. (2014). Communicating about opioids for chronic pain: A qualitative study of patient attributions and the influence of the patient–physician relationship. European Journal of Pain, 18(6), 835–843.
  • Morasco, B. J., Gritzner, S., Lewis, L., Oldham, R., Turk, D. C., & Dobscha, S. K. (2011). Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain, 152(3), 488–497.
  • Nicolaidis, C. (2011). Police officer, deal‐maker, or health care provider? Moving to a patient‐centered framework for chronic opioid management. Pain Medicine, 12(6), 890–897.
  • Samet, J. H., Friedmann, P., & Saitz, R. (2001). Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Archives of Internal Medicine, 161(1), 85–91.
  • Starrels, J. L., Becker, W. C., Alford, D. P., Kapoor, A., Williams, A. R., & Turner, B. J. (2010). Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Annals of Internal Medicine, 152(11), 712–720.
  • Sullivan, M. D., Edlund, M. J., Fan, M. Y., DeVries, A., Braden, J. B., & Martin, B. C. (2008). Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: The TROUP study. Pain, 138(2), 440–449.
  • Warner, M., Chen, L. H., & Makuc, D. M. (2009). Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. NCHS Data Brief, (22), 1–8.
  • Wen, H., Cummings, J. R., Hockenberry, J. M., Gaydos, L. M., & Druss, B. G. (2013). State parity laws and access to treatment for substance use disorder in the United States: implications for federal parity legislation. JAMA Psychiatry, 70(12), 1355–1362.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.